LC | GenomeWeb

LC

NEW YORK (GenomeWeb) – Agilent Technologies today announced a collaboration with scientists from the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research to create a comprehensive metabolomics multiple-reaction monitoring library and methodology.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 33 percent jump in revenues year over year for the second quarter, boosted by a sharp increase in its Life Sciences Solutions segment.

NEW YORK (GenomeWeb) – Certain Agilent Technologies mass spectrometers and liquid chromatography instruments now support Premier Biosoft's SimGlycan glycomics software as part of a deal announced today.

NEW YORK (GenomeWeb) – Two research teams reported on mutational patterns present in gastric cancer in Nature Genetics.

NEW YORK (GenomeWeb News) – Empiriko will use Interchim's mass spectrometry-based technology to perform drug metabolism studies as part of a partnership between the companies announced today.

NEW YORK (GenomeWeb News) – Waters today reported an 8 percent spike year over year in its fourth quarter revenues as the firm beat the average Wall Street analyst estimates on the top and bottom lines.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues for the third quarter rose 3 percent year over year as it narrowly beat the consensus Wall Street estimates on the top and bottom lines.

NEW YORK (GenomeWeb News) – Shimadzu USA Manufacturing said today it has obtained ISO 13485 certification for the manufacture of high performance liquid chromatographs and liquid chromatograph-mass spectrometry systems.

NEW YORK (GenomeWeb News) – Agilent Technologies has signed a definitive agreement to buy assets from ABC Instrumentacion Analitica, the two companies announced today.
Financial and other terms were not disclosed.

Teledyne Buying CETAC

NEW YORK (GenomeWeb News) – Teledyne Technologies this week announced that its subsidiary Teledyne Instruments has reached an agreement to buy the assets of SD Acquisition, which does business as CETAC Technologies.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.